GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » E10

PTKFY (PT Kalbe Farma Tbk) E10 : $0.86 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PT Kalbe Farma Tbk's adjusted earnings per share data for the three months ended in Sep. 2024 was $0.162. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.86 for the trailing ten years ended in Sep. 2024.

During the past 12 months, PT Kalbe Farma Tbk's average E10 Growth Rate was 2.60% per year. During the past 3 years, the average E10 Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of PT Kalbe Farma Tbk was 5.80% per year. The lowest was 2.20% per year. And the median was 4.00% per year.

As of today (2025-03-14), PT Kalbe Farma Tbk's current stock price is $13.25. PT Kalbe Farma Tbk's E10 for the quarter that ended in Sep. 2024 was $0.86. PT Kalbe Farma Tbk's Shiller PE Ratio of today is 15.41.

During the past 13 years, the highest Shiller PE Ratio of PT Kalbe Farma Tbk was 38.26. The lowest was 16.73. And the median was 27.42.


PT Kalbe Farma Tbk E10 Historical Data

The historical data trend for PT Kalbe Farma Tbk's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk E10 Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.79 0.77 0.76 1.15

PT Kalbe Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 1.15 1.27 0.73 0.86

Competitive Comparison of PT Kalbe Farma Tbk's E10

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Shiller PE Ratio falls into.



PT Kalbe Farma Tbk E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Kalbe Farma Tbk's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.162/130.3609*130.3609
=0.162

Current CPI (Sep. 2024) = 130.3609.

PT Kalbe Farma Tbk Quarterly Data

per share eps CPI Adj_EPS
201412 0.194 98.819 0.256
201503 0.173 98.388 0.229
201506 0.171 99.766 0.223
201509 0.129 101.037 0.166
201512 0.156 102.133 0.199
201603 0.182 102.764 0.231
201606 0.186 103.212 0.235
201609 0.181 104.142 0.227
201612 0.190 105.222 0.235
201703 0.188 106.476 0.230
201706 0.201 107.722 0.243
201709 0.181 108.020 0.218
201712 0.196 109.017 0.234
201803 0.183 110.097 0.217
201806 0.191 111.085 0.224
201809 0.169 111.135 0.198
201812 0.192 112.430 0.223
201903 0.179 112.829 0.207
201906 0.198 114.730 0.225
201909 0.199 114.905 0.226
201912 0.180 115.486 0.203
202003 0.187 116.252 0.210
202006 0.215 116.630 0.240
202009 0.184 116.397 0.206
202012 0.213 117.318 0.237
202103 0.212 117.840 0.235
202106 0.232 118.184 0.256
202109 0.237 118.262 0.261
202112 0.267 119.516 0.291
202203 0.249 120.948 0.268
202206 0.235 123.322 0.248
202209 0.245 125.298 0.255
202212 0.247 126.098 0.255
202303 0.240 126.953 0.246
202306 0.194 127.663 0.198
202309 0.150 128.151 0.153
202312 0.196 129.395 0.197
202403 0.264 130.607 0.264
202406 0.223 130.792 0.222
202409 0.162 130.361 0.162

Add all the adjusted EPS together and divide 10 will get our e10.


PT Kalbe Farma Tbk  (OTCPK:PTKFY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PT Kalbe Farma Tbk's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=13.25/0.86
=15.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of PT Kalbe Farma Tbk was 38.26. The lowest was 16.73. And the median was 27.42.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PT Kalbe Farma Tbk E10 Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk Headlines

No Headlines